

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vitamin A metabolic process (GO:0006776) | 6.44868440 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.41498572 |
| 3 | adhesion of symbiont to host cell (GO:0044650) | 5.95459936 |
| 4 | virion attachment to host cell (GO:0019062) | 5.95459936 |
| 5 | phospholipid efflux (GO:0033700) | 5.70432251 |
| 6 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.70382510 |
| 7 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.70382510 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.69603633 |
| 9 | plasma lipoprotein particle assembly (GO:0034377) | 5.54121202 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.51955055 |
| 11 | protein carboxylation (GO:0018214) | 5.51955055 |
| 12 | protein-lipid complex assembly (GO:0065005) | 5.35297744 |
| 13 | regulation of cholesterol esterification (GO:0010872) | 5.32400732 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 5.17503910 |
| 15 | flavonoid metabolic process (GO:0009812) | 5.11374159 |
| 16 | regulation of triglyceride catabolic process (GO:0010896) | 5.09057965 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.03333766 |
| 18 | adhesion of symbiont to host (GO:0044406) | 5.00400431 |
| 19 | digestion (GO:0007586) | 4.92073090 |
| 20 | lipoprotein metabolic process (GO:0042157) | 4.87479429 |
| 21 | cholesterol efflux (GO:0033344) | 4.87213052 |
| 22 | modified amino acid transport (GO:0072337) | 4.84937037 |
| 23 | * digestive system process (GO:0022600) | 4.72148208 |
| 24 | drug catabolic process (GO:0042737) | 4.70190499 |
| 25 | actin filament depolymerization (GO:0030042) | 4.66178638 |
| 26 | purine nucleotide salvage (GO:0032261) | 4.64365050 |
| 27 | regulation of apoptotic cell clearance (GO:2000425) | 4.53726671 |
| 28 | hormone catabolic process (GO:0042447) | 4.48588208 |
| 29 | reverse cholesterol transport (GO:0043691) | 4.45926529 |
| 30 | glucose 6-phosphate metabolic process (GO:0051156) | 4.44537421 |
| 31 | sterol transport (GO:0015918) | 4.44463134 |
| 32 | cholesterol transport (GO:0030301) | 4.44463134 |
| 33 | lipoprotein transport (GO:0042953) | 4.37820872 |
| 34 | oligosaccharide catabolic process (GO:0009313) | 4.36517663 |
| 35 | diacylglycerol metabolic process (GO:0046339) | 4.35454355 |
| 36 | pinocytosis (GO:0006907) | 4.27217879 |
| 37 | regulation of bile acid biosynthetic process (GO:0070857) | 4.23327685 |
| 38 | proline biosynthetic process (GO:0006561) | 4.15526631 |
| 39 | peptide catabolic process (GO:0043171) | 4.13350512 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.07155663 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 4.05486976 |
| 42 | plasma lipoprotein particle organization (GO:0071827) | 4.05422135 |
| 43 | protein-lipid complex subunit organization (GO:0071825) | 4.04085873 |
| 44 | cholesterol homeostasis (GO:0042632) | 4.03747301 |
| 45 | basement membrane organization (GO:0071711) | 3.99942561 |
| 46 | sterol homeostasis (GO:0055092) | 3.99895146 |
| 47 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96510003 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 3.89077977 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 3.89077977 |
| 50 | macromolecular complex remodeling (GO:0034367) | 3.89077977 |
| 51 | regulation of protein activation cascade (GO:2000257) | 3.81135954 |
| 52 | drinking behavior (GO:0042756) | 3.80333326 |
| 53 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.79973937 |
| 54 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.78093777 |
| 55 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.78093777 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 3.77742930 |
| 57 | negative regulation of sterol transport (GO:0032372) | 3.77742930 |
| 58 | proline metabolic process (GO:0006560) | 3.76977889 |
| 59 | regulation of complement activation (GO:0030449) | 3.76676878 |
| 60 | peptide hormone processing (GO:0016486) | 3.76210822 |
| 61 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.72488562 |
| 62 | response to hepatocyte growth factor (GO:0035728) | 3.72488562 |
| 63 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.65855748 |
| 64 | low-density lipoprotein particle clearance (GO:0034383) | 3.65314583 |
| 65 | negative regulation of digestive system process (GO:0060457) | 3.63381839 |
| 66 | phospholipid homeostasis (GO:0055091) | 3.60382054 |
| 67 | phenylpropanoid metabolic process (GO:0009698) | 3.55061574 |
| 68 | regulation of plasminogen activation (GO:0010755) | 3.52910504 |
| 69 | high-density lipoprotein particle remodeling (GO:0034375) | 3.47678185 |
| 70 | mannose metabolic process (GO:0006013) | 3.45823040 |
| 71 | COPI coating of Golgi vesicle (GO:0048205) | 3.41579230 |
| 72 | Golgi transport vesicle coating (GO:0048200) | 3.41579230 |
| 73 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.39312088 |
| 74 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.36864822 |
| 75 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.35026920 |
| 76 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.31352811 |
| 77 | NADH metabolic process (GO:0006734) | 3.28782723 |
| 78 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.28377283 |
| 79 | cellular carbohydrate catabolic process (GO:0044275) | 3.28192557 |
| 80 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.27078680 |
| 81 | transcytosis (GO:0045056) | 3.25900930 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 3.25206291 |
| 83 | regulation of lipoprotein metabolic process (GO:0050746) | 3.24126154 |
| 84 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.22586539 |
| 85 | sphingomyelin metabolic process (GO:0006684) | 3.19893016 |
| 86 | mature B cell differentiation involved in immune response (GO:0002313) | 3.18557023 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.17817214 |
| 88 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.17076749 |
| 89 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.15667615 |
| 90 | nucleobase catabolic process (GO:0046113) | 3.13459146 |
| 91 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.12057819 |
| 92 | protein retention in ER lumen (GO:0006621) | 3.10591318 |
| 93 | mitotic chromosome condensation (GO:0007076) | 3.02905243 |
| 94 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.02371872 |
| 95 | regulation of cholesterol transport (GO:0032374) | 3.00682427 |
| 96 | regulation of sterol transport (GO:0032371) | 3.00682427 |
| 97 | fructose metabolic process (GO:0006000) | 3.00549602 |
| 98 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.00426987 |
| 99 | response to hydroperoxide (GO:0033194) | 3.00424021 |
| 100 | neutral amino acid transport (GO:0015804) | 3.00237840 |
| 101 | positive regulation of steroid metabolic process (GO:0045940) | 2.99104019 |
| 102 | cytidine metabolic process (GO:0046087) | 2.96333347 |
| 103 | cytidine catabolic process (GO:0006216) | 2.96333347 |
| 104 | cytidine deamination (GO:0009972) | 2.96333347 |
| 105 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.96053186 |
| 106 | regulation of digestive system process (GO:0044058) | 2.95472178 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 2.95288305 |
| 108 | positive regulation of p38MAPK cascade (GO:1900745) | 2.93349004 |
| 109 | histamine secretion (GO:0001821) | 2.92402935 |
| 110 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.91499459 |
| 111 | thyroid hormone metabolic process (GO:0042403) | 2.88433012 |
| 112 | positive regulation of extracellular matrix organization (GO:1903055) | 2.87548199 |
| 113 | embryonic process involved in female pregnancy (GO:0060136) | 2.87125928 |
| 114 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.86573122 |
| 115 | lung epithelium development (GO:0060428) | 2.86379320 |
| 116 | cellular zinc ion homeostasis (GO:0006882) | 2.84198384 |
| 117 | striated muscle atrophy (GO:0014891) | 2.83024467 |
| 118 | 4-hydroxyproline metabolic process (GO:0019471) | 2.82873366 |
| 119 | beta-amyloid metabolic process (GO:0050435) | 2.81540419 |
| 120 | nucleotide salvage (GO:0043173) | 2.79571201 |
| 121 | GDP-mannose metabolic process (GO:0019673) | 2.78585133 |
| 122 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.76382528 |
| 123 | Peyers patch development (GO:0048541) | 2.76382528 |
| 124 | heterochromatin organization (GO:0070828) | 2.75884952 |
| 125 | lipid homeostasis (GO:0055088) | 2.74356849 |
| 126 | regulation of translational fidelity (GO:0006450) | 2.74085464 |
| 127 | blood coagulation, intrinsic pathway (GO:0007597) | 2.72415098 |
| 128 | glucan catabolic process (GO:0009251) | 2.72074435 |
| 129 | regulation of cholesterol metabolic process (GO:0090181) | 2.71773636 |
| 130 | intestinal epithelial cell development (GO:0060576) | 2.70831350 |
| 131 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.70773057 |
| 132 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.69468296 |
| 133 | alpha-linolenic acid metabolic process (GO:0036109) | 2.69412055 |
| 134 | positive regulation of hormone metabolic process (GO:0032352) | 2.69397964 |
| 135 | positive regulation of nuclease activity (GO:0032075) | 2.67992673 |
| 136 | urea metabolic process (GO:0019627) | 2.67679167 |
| 137 | regulation of extracellular matrix organization (GO:1903053) | 2.66438187 |
| 138 | homocysteine metabolic process (GO:0050667) | 2.66345335 |
| 139 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.66305363 |
| 140 | cell-substrate adherens junction assembly (GO:0007045) | 2.66223320 |
| 141 | focal adhesion assembly (GO:0048041) | 2.66223320 |
| 142 | regulation of actin nucleation (GO:0051125) | 2.65493003 |
| 143 | cellular polysaccharide catabolic process (GO:0044247) | 2.65421113 |
| 144 | regulation of extracellular matrix disassembly (GO:0010715) | 2.64299739 |
| 145 | urea cycle (GO:0000050) | 2.63857436 |
| 146 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.63466628 |
| 147 | vitamin transmembrane transport (GO:0035461) | 2.59233014 |
| 148 | complement activation, alternative pathway (GO:0006957) | 2.59063574 |
| 149 | response to vitamin A (GO:0033189) | 2.57411609 |
| 150 | acylglycerol catabolic process (GO:0046464) | 2.52154475 |
| 151 | neutral lipid catabolic process (GO:0046461) | 2.52154475 |
| 152 | COPII vesicle coating (GO:0048208) | 2.50453138 |
| 153 | receptor catabolic process (GO:0032801) | 2.49121917 |
| 154 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.48840730 |
| 155 | hyaluronan metabolic process (GO:0030212) | 2.47345350 |
| 156 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.47317500 |
| 157 | acute-phase response (GO:0006953) | 2.46014932 |
| 158 | positive regulation of osteoblast proliferation (GO:0033690) | 2.42238273 |
| 159 | glycosphingolipid catabolic process (GO:0046479) | 2.42216495 |
| 160 | adherens junction assembly (GO:0034333) | 2.41678702 |
| 161 | intestinal cholesterol absorption (GO:0030299) | 12.8446171 |
| 162 | * intestinal absorption (GO:0050892) | 11.2504738 |
| 163 | angiotensin maturation (GO:0002003) | 10.3059176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.93129955 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.83358110 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.58460920 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.15189771 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.98328272 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.68276980 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.65830674 |
| 8 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.55942973 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.52780269 |
| 10 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.49739151 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.49209458 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.49055321 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.40927034 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35984423 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.23770361 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.17231763 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.15922715 |
| 18 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.12920950 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08573270 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.07573881 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.06503193 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.04363069 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.00088064 |
| 24 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.97829576 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.95980184 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94407048 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.92937370 |
| 28 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.71685281 |
| 29 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69849931 |
| 30 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.69324777 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63747561 |
| 32 | GATA2_19941826_ChIP-Seq_K562_Human | 1.62347040 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.61482707 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61418448 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.60819221 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59192932 |
| 37 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.58443791 |
| 38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.58114131 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55946915 |
| 40 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54089806 |
| 41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.51490735 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.51106109 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50164522 |
| 44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48089647 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48012070 |
| 46 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.47214986 |
| 47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.45429442 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43706904 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.43640234 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42947542 |
| 51 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.42448024 |
| 52 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.41103261 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40815839 |
| 54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.39675026 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.39478367 |
| 56 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39284945 |
| 57 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38685671 |
| 58 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.37524335 |
| 59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37497771 |
| 60 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.35345589 |
| 61 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35259782 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34996813 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34768930 |
| 64 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34655904 |
| 65 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34608660 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34275256 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33848836 |
| 68 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33720860 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33434369 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32238111 |
| 71 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30492182 |
| 72 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30279764 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30202600 |
| 74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.29269145 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27578644 |
| 76 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.26574881 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25439559 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24731819 |
| 79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24352620 |
| 80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22646599 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22097261 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21434079 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21074934 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20475500 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19737563 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19691909 |
| 87 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19421655 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19060491 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18590018 |
| 90 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.18563316 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17683484 |
| 92 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16791469 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16580457 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16405495 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.16356094 |
| 96 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.16305073 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15807710 |
| 98 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15580575 |
| 99 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14413371 |
| 100 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.14350428 |
| 101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.14118918 |
| 102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.13753581 |
| 103 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.13311115 |
| 104 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13162472 |
| 105 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.12617037 |
| 106 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.12369314 |
| 107 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11699599 |
| 108 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11534595 |
| 109 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11376787 |
| 110 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.11092307 |
| 111 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.10677743 |
| 112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10656128 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09291368 |
| 114 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08686617 |
| 115 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06936007 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06894990 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06740060 |
| 118 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.06705861 |
| 119 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06307724 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05788734 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05664879 |
| 122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04489258 |
| 123 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.03924905 |
| 124 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03697838 |
| 125 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03567193 |
| 126 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03432714 |
| 127 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.01808828 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01762906 |
| 129 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01295238 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01085894 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00771009 |
| 132 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99699701 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98902525 |
| 134 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98376833 |
| 135 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97694501 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97350108 |
| 137 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96735465 |
| 138 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95647622 |
| 139 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95564817 |
| 140 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.95525076 |
| 141 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95395163 |
| 142 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.95035954 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94714115 |
| 144 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94255991 |
| 145 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93699324 |
| 146 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90865871 |
| 147 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90684360 |
| 148 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89019703 |
| 149 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88675939 |
| 150 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88033919 |
| 151 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87811461 |
| 152 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86268345 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85441896 |
| 154 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84741412 |
| 155 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82983028 |
| 156 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82439355 |
| 157 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82060092 |
| 158 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81532101 |
| 159 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.81459144 |
| 160 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81383383 |
| 161 | * P68_20966046_ChIP-Seq_HELA_Human | 0.81192283 |
| 162 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81125060 |
| 163 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80032685 |
| 164 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79994358 |
| 165 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78936850 |
| 166 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78816722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001666_abnormal_nutrient_absorption | 7.34525053 |
| 2 | * MP0005360_urolithiasis | 6.92381010 |
| 3 | MP0009840_abnormal_foam_cell | 5.60636394 |
| 4 | MP0003183_abnormal_peptide_metabolism | 4.30733307 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.68378645 |
| 6 | MP0004264_abnormal_extraembryonic_tissu | 3.42956712 |
| 7 | MP0003252_abnormal_bile_duct | 3.36429756 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.93032746 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.81865585 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.76688151 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.55552632 |
| 12 | MP0000566_synostosis | 2.48625219 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.48460127 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.48361170 |
| 15 | MP0003866_abnormal_defecation | 2.42736955 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.36754495 |
| 17 | MP0004147_increased_porphyrin_level | 2.36249988 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.33346664 |
| 19 | MP0004272_abnormal_basement_membrane | 2.29943877 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 2.25827577 |
| 21 | MP0005076_abnormal_cell_differentiation | 2.24056394 |
| 22 | MP0000462_abnormal_digestive_system | 2.22871575 |
| 23 | MP0003123_paternal_imprinting | 2.21275548 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.18660751 |
| 25 | MP0003122_maternal_imprinting | 2.16652636 |
| 26 | MP0005257_abnormal_intraocular_pressure | 2.09928718 |
| 27 | MP0005365_abnormal_bile_salt | 2.07089506 |
| 28 | MP0002254_reproductive_system_inflammat | 1.97929047 |
| 29 | MP0001849_ear_inflammation | 1.91519240 |
| 30 | MP0001873_stomach_inflammation | 1.90480750 |
| 31 | MP0004043_abnormal_pH_regulation | 1.90136071 |
| 32 | MP0009697_abnormal_copulation | 1.85746514 |
| 33 | MP0008260_abnormal_autophagy | 1.80280511 |
| 34 | MP0001915_intracranial_hemorrhage | 1.79491488 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.76068118 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.71835448 |
| 37 | MP0004858_abnormal_nervous_system | 1.65149178 |
| 38 | MP0003111_abnormal_nucleus_morphology | 1.64797029 |
| 39 | MP0005448_abnormal_energy_balance | 1.61156600 |
| 40 | MP0005409_darkened_coat_color | 1.60430605 |
| 41 | MP0001664_abnormal_digestion | 1.58888880 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.58343715 |
| 43 | MP0003878_abnormal_ear_physiology | 1.58343715 |
| 44 | * MP0001663_abnormal_digestive_system | 1.54402003 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.52434063 |
| 46 | MP0005451_abnormal_body_composition | 1.51128802 |
| 47 | MP0000538_abnormal_urinary_bladder | 1.50056203 |
| 48 | MP0005332_abnormal_amino_acid | 1.49656241 |
| 49 | MP0003693_abnormal_embryo_hatching | 1.47792543 |
| 50 | * MP0005381_digestive/alimentary_phenotyp | 1.42515000 |
| 51 | MP0001730_embryonic_growth_arrest | 1.39175061 |
| 52 | MP0010030_abnormal_orbit_morphology | 1.38895225 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.38894769 |
| 54 | MP0000490_abnormal_crypts_of | 1.38536757 |
| 55 | MP0001661_extended_life_span | 1.36299123 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.30624547 |
| 57 | MP0000604_amyloidosis | 1.30294679 |
| 58 | MP0000858_altered_metastatic_potential | 1.29875161 |
| 59 | MP0004233_abnormal_muscle_weight | 1.29531802 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.29244766 |
| 61 | MP0000477_abnormal_intestine_morphology | 1.26061652 |
| 62 | MP0005408_hypopigmentation | 1.25283362 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.23278045 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 1.22354210 |
| 65 | MP0003646_muscle_fatigue | 1.19997557 |
| 66 | MP0002132_abnormal_respiratory_system | 1.16624340 |
| 67 | MP0003718_maternal_effect | 1.14865959 |
| 68 | MP0000609_abnormal_liver_physiology | 1.14536321 |
| 69 | MP0009384_cardiac_valve_regurgitation | 1.12445622 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.09968594 |
| 71 | MP0002396_abnormal_hematopoietic_system | 1.08207540 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.05680651 |
| 73 | MP0005380_embryogenesis_phenotype | 1.05115504 |
| 74 | MP0001672_abnormal_embryogenesis/_devel | 1.05115504 |
| 75 | MP0002822_catalepsy | 1.05112767 |
| 76 | MP0008932_abnormal_embryonic_tissue | 1.04551829 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 1.04203391 |
| 78 | MP0000767_abnormal_smooth_muscle | 1.04132764 |
| 79 | MP0003984_embryonic_growth_retardation | 1.03532456 |
| 80 | MP0003315_abnormal_perineum_morphology | 1.02521237 |
| 81 | MP0000003_abnormal_adipose_tissue | 1.02003171 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.01569392 |
| 83 | MP0005023_abnormal_wound_healing | 1.01054487 |
| 84 | MP0003115_abnormal_respiratory_system | 0.98413800 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.96630775 |
| 86 | MP0009672_abnormal_birth_weight | 0.96076590 |
| 87 | * MP0009643_abnormal_urine_homeostasis | 0.95399379 |
| 88 | MP0009764_decreased_sensitivity_to | 0.94987514 |
| 89 | MP0000598_abnormal_liver_morphology | 0.93166674 |
| 90 | MP0003950_abnormal_plasma_membrane | 0.91319844 |
| 91 | MP0005266_abnormal_metabolism | 0.90804317 |
| 92 | MP0002080_prenatal_lethality | 0.89188134 |
| 93 | MP0009115_abnormal_fat_cell | 0.89165044 |
| 94 | MP0003329_amyloid_beta_deposits | 0.85560074 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.85048068 |
| 96 | MP0005310_abnormal_salivary_gland | 0.84952931 |
| 97 | MP0002933_joint_inflammation | 0.84001398 |
| 98 | MP0001697_abnormal_embryo_size | 0.83610708 |
| 99 | MP0002060_abnormal_skin_morphology | 0.83027818 |
| 100 | MP0004947_skin_inflammation | 0.82170964 |
| 101 | MP0002092_abnormal_eye_morphology | 0.81331499 |
| 102 | MP0005166_decreased_susceptibility_to | 0.80908033 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.79518709 |
| 104 | MP0005501_abnormal_skin_physiology | 0.78814243 |
| 105 | MP0003195_calcinosis | 0.78527567 |
| 106 | MP0006138_congestive_heart_failure | 0.78316970 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.77887448 |
| 108 | MP0003942_abnormal_urinary_system | 0.77056539 |
| 109 | MP0003941_abnormal_skin_development | 0.75906345 |
| 110 | MP0005083_abnormal_biliary_tract | 0.75865545 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.74755084 |
| 112 | MP0002148_abnormal_hypersensitivity_rea | 0.72558025 |
| 113 | MP0010630_abnormal_cardiac_muscle | 0.71784714 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.71388574 |
| 115 | MP0003091_abnormal_cell_migration | 0.71199470 |
| 116 | MP0006054_spinal_hemorrhage | 0.70731230 |
| 117 | MP0009333_abnormal_splenocyte_physiolog | 0.69781877 |
| 118 | MP0003077_abnormal_cell_cycle | 0.69703773 |
| 119 | MP0001881_abnormal_mammary_gland | 0.68511897 |
| 120 | MP0002419_abnormal_innate_immunity | 0.67444412 |
| 121 | MP0002697_abnormal_eye_size | 0.66592006 |
| 122 | MP0000350_abnormal_cell_proliferation | 0.66248834 |
| 123 | MP0010094_abnormal_chromosome_stability | 0.65616550 |
| 124 | MP0005330_cardiomyopathy | 0.65256218 |
| 125 | MP0005621_abnormal_cell_physiology | 0.65185191 |
| 126 | MP0000537_abnormal_urethra_morphology | 0.64159685 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.63959989 |
| 128 | MP0008469_abnormal_protein_level | 0.63633076 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.62703440 |
| 130 | MP0003436_decreased_susceptibility_to | 0.62485006 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62146089 |
| 132 | MP0000747_muscle_weakness | 0.62130409 |
| 133 | MP0001764_abnormal_homeostasis | 0.61590961 |
| 134 | * MP0009642_abnormal_blood_homeostasis | 0.59696517 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.58340185 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.54971509 |
| 137 | MP0000678_abnormal_parathyroid_gland | 0.54423891 |
| 138 | MP0005025_abnormal_response_to | 0.54259626 |
| 139 | MP0000467_abnormal_esophagus_morphology | 0.53750836 |
| 140 | MP0005334_abnormal_fat_pad | 0.53378532 |
| 141 | MP0009785_altered_susceptibility_to | 0.53365143 |
| 142 | MP0002452_abnormal_antigen_presenting | 0.51379549 |
| 143 | MP0000579_abnormal_nail_morphology | 0.51330917 |
| 144 | * MP0002136_abnormal_kidney_physiology | 0.51222610 |
| 145 | MP0003656_abnormal_erythrocyte_physiolo | 0.50868206 |
| 146 | MP0000249_abnormal_blood_vessel | 0.50476145 |
| 147 | MP0003075_altered_response_to | 0.48805642 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.48752966 |
| 149 | MP0005165_increased_susceptibility_to | 0.47401624 |
| 150 | MP0003868_abnormal_feces_composition | 0.47270194 |
| 151 | MP0006082_CNS_inflammation | 0.47053819 |
| 152 | MP0002971_abnormal_brown_adipose | 0.46575897 |
| 153 | MP0005174_abnormal_tail_pigmentation | 0.45725267 |
| 154 | MP0000427_abnormal_hair_cycle | 0.44992087 |
| 155 | MP0002653_abnormal_ependyma_morphology | 0.44490930 |
| 156 | MP0003828_pulmonary_edema | 0.43814363 |
| 157 | MP0001819_abnormal_immune_cell | 0.43237140 |
| 158 | MP0009765_abnormal_xenobiotic_induced | 0.42346913 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.40734978 |
| 160 | MP0002420_abnormal_adaptive_immunity | 0.40494835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 7.33155328 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.81896705 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.72118074 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.29628338 |
| 5 | Acanthocytosis (HP:0001927) | 6.27041247 |
| 6 | Ileus (HP:0002595) | 6.18462230 |
| 7 | Hydroxyprolinuria (HP:0003080) | 5.87631029 |
| 8 | Abnormality of proline metabolism (HP:0010907) | 5.87631029 |
| 9 | Malnutrition (HP:0004395) | 5.37578143 |
| 10 | Mesangial abnormality (HP:0001966) | 4.87753150 |
| 11 | Pigmentary retinal degeneration (HP:0001146) | 4.79733044 |
| 12 | Hyperglycinuria (HP:0003108) | 4.58534153 |
| 13 | Cupped ribs (HP:0000887) | 4.50785534 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 4.31728450 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.01178335 |
| 16 | B lymphocytopenia (HP:0010976) | 3.98327740 |
| 17 | Abnormality of B cell number (HP:0010975) | 3.98327740 |
| 18 | Conjugated hyperbilirubinemia (HP:0002908) | 3.97845824 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.88700340 |
| 20 | Fat malabsorption (HP:0002630) | 3.78523387 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 3.77293122 |
| 22 | Joint hemorrhage (HP:0005261) | 3.76131032 |
| 23 | Poikilocytosis (HP:0004447) | 3.73940075 |
| 24 | Chronic diarrhea (HP:0002028) | 3.69414804 |
| 25 | Increased IgE level (HP:0003212) | 3.68180435 |
| 26 | Hemorrhage of the eye (HP:0011885) | 3.64859927 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.61619421 |
| 28 | Hypoproteinemia (HP:0003075) | 3.61316718 |
| 29 | Combined immunodeficiency (HP:0005387) | 3.59272903 |
| 30 | Thyroiditis (HP:0100646) | 3.37098519 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.17817857 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17817857 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.10895471 |
| 34 | Protrusio acetabuli (HP:0003179) | 3.10308656 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.09882254 |
| 36 | Abnormality of carpal bone ossification (HP:0006257) | 3.06932831 |
| 37 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.06446858 |
| 38 | Abdominal distention (HP:0003270) | 3.05216891 |
| 39 | Xanthomatosis (HP:0000991) | 3.03874181 |
| 40 | Widely patent fontanelles and sutures (HP:0004492) | 3.03307327 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 2.93937885 |
| 42 | Small epiphyses (HP:0010585) | 2.92817391 |
| 43 | Premature rupture of membranes (HP:0001788) | 2.91786833 |
| 44 | Facial shape deformation (HP:0011334) | 2.82996291 |
| 45 | Potter facies (HP:0002009) | 2.82996291 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.82356232 |
| 47 | Abnormality of vitamin B metabolism (HP:0004340) | 2.79895696 |
| 48 | Abnormal glucose tolerance (HP:0001952) | 2.76731236 |
| 49 | Reticulocytosis (HP:0001923) | 2.75818440 |
| 50 | Menorrhagia (HP:0000132) | 2.73496569 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.70805266 |
| 52 | Glycosuria (HP:0003076) | 2.64587011 |
| 53 | Abnormality of urine glucose concentration (HP:0011016) | 2.64587011 |
| 54 | Abnormal ossification of hand bones (HP:0005921) | 2.63685532 |
| 55 | Increased mean platelet volume (HP:0011877) | 2.61880112 |
| 56 | Complement deficiency (HP:0004431) | 2.61796584 |
| 57 | Broad palm (HP:0001169) | 2.60775498 |
| 58 | Ulnar bowing (HP:0003031) | 2.55753289 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.53474828 |
| 60 | Myocardial infarction (HP:0001658) | 2.53381211 |
| 61 | Vertebral compression fractures (HP:0002953) | 2.51078466 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.51024388 |
| 63 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.50074581 |
| 64 | Abnormality of complement system (HP:0005339) | 2.49294175 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.47782407 |
| 66 | Gingivitis (HP:0000230) | 2.44522063 |
| 67 | Polycythemia (HP:0001901) | 2.43951517 |
| 68 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.41766281 |
| 69 | Dehydration (HP:0001944) | 2.41375371 |
| 70 | Abnormal tarsal ossification (HP:0008369) | 2.40522760 |
| 71 | Pustule (HP:0200039) | 2.40339840 |
| 72 | Cervical subluxation (HP:0003308) | 2.37323884 |
| 73 | Abnormal platelet volume (HP:0011876) | 2.37019358 |
| 74 | Abnormality of the lumbar spine (HP:0100712) | 2.36074637 |
| 75 | Glomerulonephritis (HP:0000099) | 2.36057620 |
| 76 | Eosinophilia (HP:0001880) | 2.34396724 |
| 77 | Broad alveolar ridges (HP:0000187) | 2.34061536 |
| 78 | Abnormality of the acetabulum (HP:0003170) | 2.33632257 |
| 79 | Gastrointestinal dysmotility (HP:0002579) | 2.33602803 |
| 80 | Confusion (HP:0001289) | 2.32529314 |
| 81 | Epidermoid cyst (HP:0200040) | 2.32223065 |
| 82 | Nausea (HP:0002018) | 2.31009549 |
| 83 | Biconcave vertebral bodies (HP:0004586) | 2.30113854 |
| 84 | Syncope (HP:0001279) | 2.29067844 |
| 85 | Asymmetry of the thorax (HP:0001555) | 2.27002840 |
| 86 | Abnormal hand bone ossification (HP:0010660) | 2.23073013 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.22299248 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 2.21732145 |
| 89 | Cheilitis (HP:0100825) | 2.20648705 |
| 90 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.17912643 |
| 91 | Absent epiphyses (HP:0010577) | 2.17912643 |
| 92 | Megaloblastic anemia (HP:0001889) | 2.17519721 |
| 93 | Renal duplication (HP:0000075) | 2.16866216 |
| 94 | Nephrolithiasis (HP:0000787) | 2.15736068 |
| 95 | Recurrent viral infections (HP:0004429) | 2.13118548 |
| 96 | Epiphyseal dysplasia (HP:0002656) | 2.12636369 |
| 97 | Vaginal fistula (HP:0004320) | 2.11029130 |
| 98 | Metabolic acidosis (HP:0001942) | 2.10313505 |
| 99 | Disproportionate tall stature (HP:0001519) | 2.09943728 |
| 100 | Recurrent fungal infections (HP:0002841) | 2.08805566 |
| 101 | Abnormality of vitamin metabolism (HP:0100508) | 2.08264275 |
| 102 | Palpitations (HP:0001962) | 2.07499892 |
| 103 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.07308082 |
| 104 | Nonimmune hydrops fetalis (HP:0001790) | 2.06010699 |
| 105 | Abnormal foot bone ossification (HP:0010675) | 2.05327306 |
| 106 | Neonatal death (HP:0003811) | 2.02767101 |
| 107 | Vascular calcification (HP:0004934) | 2.01569963 |
| 108 | Hyperammonemia (HP:0001987) | 2.00303291 |
| 109 | Purpura (HP:0000979) | 1.98835899 |
| 110 | Flat acetabular roof (HP:0003180) | 1.98774667 |
| 111 | Irregular epiphyses (HP:0010582) | 1.98674942 |
| 112 | Limited elbow extension (HP:0001377) | 1.98040533 |
| 113 | Granulocytopenia (HP:0001913) | 1.95305542 |
| 114 | Hypoalbuminemia (HP:0003073) | 1.93099297 |
| 115 | Abnormal albumin level (HP:0012116) | 1.93099297 |
| 116 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.91746450 |
| 117 | Abnormality of the gastric mucosa (HP:0004295) | 1.89189354 |
| 118 | Eczematoid dermatitis (HP:0000976) | 1.88953891 |
| 119 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87714310 |
| 120 | Skin nodule (HP:0200036) | 1.86067496 |
| 121 | Coxa vara (HP:0002812) | 1.85485934 |
| 122 | Wide nose (HP:0000445) | 1.83494084 |
| 123 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.83223473 |
| 124 | Villous atrophy (HP:0011473) | 1.83223473 |
| 125 | Cardiovascular calcification (HP:0011915) | 1.82997760 |
| 126 | Rectal prolapse (HP:0002035) | 1.82511647 |
| 127 | Vacuolated lymphocytes (HP:0001922) | 1.82478900 |
| 128 | Blue sclerae (HP:0000592) | 1.81961816 |
| 129 | Congenital sensorineural hearing impairment (HP:0008527) | 1.81554184 |
| 130 | Pancreatitis (HP:0001733) | 1.80583085 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.80549156 |
| 132 | Progressive sensorineural hearing impairment (HP:0000408) | 1.80417193 |
| 133 | Abnormal platelet function (HP:0011869) | 1.79216588 |
| 134 | Impaired platelet aggregation (HP:0003540) | 1.79216588 |
| 135 | Hepatocellular carcinoma (HP:0001402) | 1.78150821 |
| 136 | Bundle branch block (HP:0011710) | 1.77741356 |
| 137 | Fatigue (HP:0012378) | 1.77347021 |
| 138 | Enlarged kidneys (HP:0000105) | 1.76283017 |
| 139 | Thin bony cortex (HP:0002753) | 1.75916000 |
| 140 | Wide cranial sutures (HP:0010537) | 1.75613921 |
| 141 | Peripheral demyelination (HP:0011096) | 1.75380245 |
| 142 | Shallow orbits (HP:0000586) | 1.75374548 |
| 143 | Hyperacusis (HP:0010780) | 1.74798631 |
| 144 | Flared iliac wings (HP:0002869) | 1.74621970 |
| 145 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74146303 |
| 146 | Mucopolysacchariduria (HP:0008155) | 1.74146303 |
| 147 | Abnormal delivery (HP:0001787) | 1.73965586 |
| 148 | Reduced antithrombin III activity (HP:0001976) | 1.73608952 |
| 149 | Abnormal vertebral ossification (HP:0100569) | 1.73563084 |
| 150 | Dislocated radial head (HP:0003083) | 1.72318950 |
| 151 | Mitral stenosis (HP:0001718) | 1.70408441 |
| 152 | Gingival bleeding (HP:0000225) | 1.70310325 |
| 153 | Abnormality of the thoracic spine (HP:0100711) | 1.70230941 |
| 154 | Cholecystitis (HP:0001082) | 1.69269637 |
| 155 | Abnormal gallbladder physiology (HP:0012438) | 1.69269637 |
| 156 | Amyloidosis (HP:0011034) | 1.69060052 |
| 157 | Advanced eruption of teeth (HP:0006288) | 1.68032055 |
| 158 | Sensorimotor neuropathy (HP:0007141) | 1.67581499 |
| 159 | Myopathic facies (HP:0002058) | 1.67264300 |
| 160 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.67155499 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.67155499 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.67155499 |
| 163 | Long palpebral fissure (HP:0000637) | 1.67057693 |
| 164 | Achilles tendon contracture (HP:0001771) | 1.66466263 |
| 165 | Hypoalphalipoproteinemia (HP:0003233) | 1.66278526 |
| 166 | Colitis (HP:0002583) | 1.65542377 |
| 167 | Abnormality of reticulocytes (HP:0004312) | 1.65427431 |
| 168 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.64974065 |
| 169 | Vitreoretinal degeneration (HP:0000655) | 1.64449218 |
| 170 | Aneurysm (HP:0002617) | 1.63913223 |
| 171 | Diastasis recti (HP:0001540) | 1.62027321 |
| 172 | Hepatoblastoma (HP:0002884) | 1.61731005 |
| 173 | Metaphyseal cupping (HP:0003021) | 1.61074798 |
| 174 | Premature skin wrinkling (HP:0100678) | 1.60650863 |
| 175 | 11 pairs of ribs (HP:0000878) | 1.58870440 |
| 176 | Heterotopia (HP:0002282) | 1.58857790 |
| 177 | Protuberant abdomen (HP:0001538) | 1.57064395 |
| 178 | J-shaped sella turcica (HP:0002680) | 1.55856082 |
| 179 | Broad face (HP:0000283) | 1.54985746 |
| 180 | Delayed epiphyseal ossification (HP:0002663) | 1.54716170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.84503148 |
| 2 | FGFR4 | 4.61172302 |
| 3 | LMTK2 | 4.37216024 |
| 4 | MST4 | 4.30489806 |
| 5 | PRPF4B | 3.53708987 |
| 6 | SMG1 | 3.35692634 |
| 7 | MST1R | 3.17466677 |
| 8 | GRK6 | 3.15975744 |
| 9 | NME1 | 3.14176712 |
| 10 | ERN1 | 2.76918765 |
| 11 | PRKG2 | 2.59933860 |
| 12 | MAP3K10 | 2.44200902 |
| 13 | AKT3 | 2.40476996 |
| 14 | PTK6 | 2.22412644 |
| 15 | SIK1 | 2.17236446 |
| 16 | PDGFRA | 2.15960868 |
| 17 | RIPK1 | 2.10662721 |
| 18 | TYRO3 | 2.00848169 |
| 19 | FGFR3 | 1.99438076 |
| 20 | CDK12 | 1.85859341 |
| 21 | MAP2K3 | 1.79633640 |
| 22 | MAP2K2 | 1.76993733 |
| 23 | RIPK4 | 1.72802485 |
| 24 | STK10 | 1.70317658 |
| 25 | MAP4K1 | 1.60051197 |
| 26 | TAOK3 | 1.56712558 |
| 27 | NUAK1 | 1.52047428 |
| 28 | TYK2 | 1.49907405 |
| 29 | IRAK3 | 1.48280804 |
| 30 | SCYL2 | 1.45127486 |
| 31 | LATS1 | 1.44946887 |
| 32 | WNK4 | 1.37955461 |
| 33 | STK24 | 1.36780174 |
| 34 | KSR2 | 1.31174075 |
| 35 | NME2 | 1.28300855 |
| 36 | CDC42BPA | 1.23617900 |
| 37 | MAP3K7 | 1.22785868 |
| 38 | CDK7 | 1.21938134 |
| 39 | EPHA2 | 1.20471760 |
| 40 | PAK4 | 1.19959780 |
| 41 | MAP3K6 | 1.19104945 |
| 42 | BMX | 1.18453426 |
| 43 | TAOK1 | 1.15394141 |
| 44 | PKN2 | 1.11431087 |
| 45 | MET | 1.11193858 |
| 46 | MTOR | 1.09761374 |
| 47 | MAP3K13 | 1.09400591 |
| 48 | TRIB3 | 1.08950262 |
| 49 | FGFR1 | 1.05962668 |
| 50 | TBK1 | 1.05768583 |
| 51 | NEK2 | 1.04260390 |
| 52 | EPHB1 | 1.03867235 |
| 53 | MAP3K2 | 1.02291130 |
| 54 | MUSK | 0.99781003 |
| 55 | TESK2 | 0.94574552 |
| 56 | CAMK1D | 0.94554282 |
| 57 | PRKAA2 | 0.93115212 |
| 58 | PBK | 0.92835235 |
| 59 | MAPK11 | 0.89954817 |
| 60 | PDK2 | 0.87663031 |
| 61 | BRD4 | 0.86369647 |
| 62 | FGFR2 | 0.86247272 |
| 63 | CDK9 | 0.84987970 |
| 64 | MAP3K8 | 0.83981156 |
| 65 | STK3 | 0.83683558 |
| 66 | TTK | 0.83629007 |
| 67 | MAP3K3 | 0.79972429 |
| 68 | MAP3K14 | 0.77633932 |
| 69 | FLT3 | 0.77396383 |
| 70 | SIK2 | 0.75792262 |
| 71 | BRSK1 | 0.75399698 |
| 72 | TAOK2 | 0.74119852 |
| 73 | WNK1 | 0.73452326 |
| 74 | ZAP70 | 0.73435165 |
| 75 | CDK4 | 0.70503932 |
| 76 | BRAF | 0.70210534 |
| 77 | EEF2K | 0.68348089 |
| 78 | PRKAA1 | 0.67149854 |
| 79 | DYRK1B | 0.64250707 |
| 80 | ERBB4 | 0.63743459 |
| 81 | NTRK1 | 0.63355094 |
| 82 | MAP3K11 | 0.61155166 |
| 83 | EPHB2 | 0.60859477 |
| 84 | LATS2 | 0.60707584 |
| 85 | EIF2AK1 | 0.59546103 |
| 86 | RET | 0.59100236 |
| 87 | MAP3K1 | 0.58677010 |
| 88 | TGFBR2 | 0.57277065 |
| 89 | FGR | 0.57085555 |
| 90 | MARK2 | 0.55081659 |
| 91 | PDPK1 | 0.54445442 |
| 92 | CDK8 | 0.53968256 |
| 93 | CHEK1 | 0.53961076 |
| 94 | PIK3CG | 0.53611458 |
| 95 | MATK | 0.53570547 |
| 96 | CSK | 0.53156553 |
| 97 | MAP3K9 | 0.52961280 |
| 98 | STK38L | 0.52926490 |
| 99 | YES1 | 0.52924549 |
| 100 | JAK1 | 0.51513346 |
| 101 | NEK1 | 0.49923251 |
| 102 | TTN | 0.49889539 |
| 103 | CDK6 | 0.49119818 |
| 104 | IRAK2 | 0.45121932 |
| 105 | PDGFRB | 0.44256599 |
| 106 | PRKCQ | 0.42774497 |
| 107 | PTK2 | 0.42492838 |
| 108 | MAP2K6 | 0.42412542 |
| 109 | MELK | 0.40456266 |
| 110 | PHKG1 | 0.40451314 |
| 111 | PHKG2 | 0.40451314 |
| 112 | DMPK | 0.39884073 |
| 113 | ITK | 0.38475267 |
| 114 | PDK1 | 0.37887398 |
| 115 | IKBKE | 0.37291264 |
| 116 | NEK9 | 0.37248703 |
| 117 | PRKD2 | 0.36509132 |
| 118 | JAK2 | 0.35346548 |
| 119 | TNIK | 0.34801311 |
| 120 | CAMK1G | 0.34492213 |
| 121 | CHEK2 | 0.33564917 |
| 122 | PIM1 | 0.32130165 |
| 123 | VRK2 | 0.31911236 |
| 124 | PAK2 | 0.31904620 |
| 125 | KIT | 0.31754887 |
| 126 | MAP2K1 | 0.31453967 |
| 127 | RPS6KB2 | 0.31091229 |
| 128 | DDR2 | 0.30124822 |
| 129 | RPS6KA2 | 0.29961899 |
| 130 | ARAF | 0.28906405 |
| 131 | ROCK1 | 0.28779010 |
| 132 | JAK3 | 0.28546365 |
| 133 | STK4 | 0.28501773 |
| 134 | AKT2 | 0.27987912 |
| 135 | PRKCD | 0.26860881 |
| 136 | PRKCI | 0.26535227 |
| 137 | PIM2 | 0.24307430 |
| 138 | ABL1 | 0.23346474 |
| 139 | MAPKAPK2 | 0.22882170 |
| 140 | IRAK4 | 0.22608594 |
| 141 | PRKCA | 0.22481076 |
| 142 | SGK3 | 0.22436480 |
| 143 | MAPK12 | 0.22349784 |
| 144 | ICK | 0.21256375 |
| 145 | SRC | 0.19665286 |
| 146 | PAK3 | 0.19156889 |
| 147 | ERBB2 | 0.18465242 |
| 148 | MYLK | 0.18151830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.18138464 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.01748201 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.32265317 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.11600443 |
| 5 | * Mineral absorption_Homo sapiens_hsa04978 | 3.36920287 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.33563345 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.16141229 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 3.03096622 |
| 9 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.86323486 |
| 10 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.85176110 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.78609553 |
| 12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.42520058 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.19927894 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.99892172 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.95064126 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85571711 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.72855058 |
| 18 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.67312107 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55444757 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53642179 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52089927 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42688659 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39635727 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39625146 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.33555167 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.31764874 |
| 27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.30721788 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.30599907 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20001374 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.14655503 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13266866 |
| 32 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.11938620 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.09669962 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08729799 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07098508 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06066875 |
| 37 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.04513742 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.03686946 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02887003 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01766063 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98992417 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97015890 |
| 43 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95622431 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95612391 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95580891 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95411191 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95051582 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94702673 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92681648 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91588344 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91210367 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91011698 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90194288 |
| 54 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89763083 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88789126 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87795775 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87037029 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86715817 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82826959 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81155673 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78935172 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78272084 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76939393 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75527014 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75469085 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75177105 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75013564 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74476222 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73280459 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71182723 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69717586 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.69057358 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.67394807 |
| 74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67354759 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64422979 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64346205 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63585618 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63327230 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61757249 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60898365 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.59368366 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54230832 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54150190 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53116124 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52999201 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50355226 |
| 87 | Cell cycle_Homo sapiens_hsa04110 | 0.49987724 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49705359 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49326567 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49191806 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49133536 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49105677 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48028464 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.47497189 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47391644 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47291463 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45705457 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45047704 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44738148 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43916122 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.43901369 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42837892 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42666853 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.41472984 |
| 105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40672734 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40001208 |
| 107 | Mismatch repair_Homo sapiens_hsa03430 | 0.38738618 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36551403 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35860865 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35791965 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.34034909 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33566388 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32016210 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31925386 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31636857 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.30288269 |
| 117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30011392 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.29907863 |
| 119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29779323 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.28375385 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.27266526 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25790012 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.25787603 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.25394640 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24689359 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.24075343 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23445066 |
| 128 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21297345 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.19840229 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18219008 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.17946810 |
| 132 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.16064192 |
| 133 | Leishmaniasis_Homo sapiens_hsa05140 | 0.15129873 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14775959 |
| 135 | Tight junction_Homo sapiens_hsa04530 | 0.13716701 |
| 136 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.11683702 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | 0.11572515 |
| 138 | Lysosome_Homo sapiens_hsa04142 | 0.10669107 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10030814 |
| 140 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.09599801 |
| 141 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.08145066 |
| 142 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.07972050 |
| 143 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.07549009 |
| 144 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.06754755 |
| 145 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.06498214 |
| 146 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06323134 |
| 147 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.05020313 |
| 148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04199136 |
| 149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.03341546 |
| 150 | Pertussis_Homo sapiens_hsa05133 | 0.03043751 |

